Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SIRT2 contributors: mct - updated : 17-10-2019
HGNC name sirtuin 2
HGNC id 10886
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --low  
down-regulated in gliomas and glioma cell lines, which are characterized by aneuploidy
constitutional     --low  
in both preeclampsia (PE) and fetal growth restriction (FGR)
constitutional     --low  
of SIRT2 protein expression in both Preeclampsia (PE) and fetal growth restriction (FGR) placentas
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
neurologyneurodegenerativehuntington chorea
SIRT2 inhibition is a promising avenue for HD therapy
neuromuscularmyopathycongenital
SIRT2 inhibitors and AMPK inhibitors as potential therapeutics for OPMD and perhaps other muscular dystrophies and polyAla diseases
cancer  
utilization of sirtuin activators that specifically target SIRT2 could serve as potential anticancer therapy
miscelleaneous  
SIRT2 targeting may be therapeutically beneficial in diseases where aggregation of misfolded proteins is central to disease pathogenesis
neurologyneurodegenerative 
viable molecular target for neuroprotective therapy.
neurologyneurodegenerative 
therapeutic target in the most prevalent neurodegenerative diseases that undergo with axonal degeneration associated with redox and energetic dyshomeostasis
cardiovascularaquired 
potential target for therapeutic interventions in aging- and stress-induced cardiac hypertrophy
cancerhemopathy 
SIRT2 serves as a promising target for further therapeutic investigations
neurologyneurodegenerativeParkinson/dementia Parkinsonism
inhibition of Sirtuin 2 expression may be a neuroprotective measure in Parkinson's disease
ANIMAL & CELL MODELS